Kezar Life Sciences, Inc. (KZR)
7.33
-0.04
(-0.54%)
USD |
NASDAQ |
Apr 17, 16:00
7.34
+0.01
(+0.14%)
After-Hours: 20:00
Kezar Life Sciences Total Assets (Quarterly) : 76.65M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Apellis Pharmaceuticals, Inc. | 1.075B |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
| BioMarin Pharmaceutical, Inc. | 7.594B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.574M |
| Shareholders Equity (Quarterly) | 70.07M |
| Debt to Equity Ratio | 0.0332 |
| Current Ratio | 11.52 |
| Net Debt Paydown Yield | 6.33% |